19:10 - 21:00
Room: Ishikawa Ongakudō Interchange Hall
Poster Session
Glial galectin-9 plays a novel role in hypoxic tumor environment
Chi Young Chang1, Seungtae Baek1, 3, Hyung-Seok Kim1, Sae-Bom Jeon1, Randall S. Johnson2, Eun Jung Park1, 3
1Immunotherapeutic Branch, National Cancer Center, Goyang, Korea, Republic of (South), 2Department of Physiology, Development and Neuroscience, University of Cambridge, CB2 3EG Cambridge, United Kingdom, 3Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea, Republic of (South)

Malignant brain tumors contain a hypoxic environment rich in infiltrates of inflammatory glial cells that may influence tumor progression and T-cell function. Here, we present that hypoxia-induced glial Galectin-9 (Gal9) function as a modulator of innate immune response against tumor in a hypoxia-inducible factor (HIF)-2α-dependent manner. In vitro and in vivo, glial Gal9 highly expressed not only in hypoxic tumor region of mouse tumor model, but also in activated glia responding to tumor. Notably, expression and production of Gal9 is distinctively regulated dependent on HIF-2α, but not HIF-1α using tissue targeted mutant mice. Collectively, our data suggest that Gal9 secreted from activated glia in hypoxic tumor region and contribute to immunosuppressive environment.


Reference:
Tu-P14-43
Session:
Poster Session 14 “Cytokines in cancer development and antitumor immune therapy”
Presenter/s:
Seungtae Baek
Presentation type:
Poster Presentation
Room:
Ishikawa Ongakudō Interchange Hall
Date:
Tuesday, 31 October 2017
Time:
19:10 - 21:00
Session times:
19:10 - 21:00